Innovation Ventures is Proud to Present Our Catalyst Awardees!
The 2025-2026 Catalyst Accelerator cycle has been a transformative period with exciting results! The caliber of applicants and awardees in this competitive Catalyst class is remarkable. We are pleased to announce the Awardees of this year’s Catalyst Final Awards and the Weill Institute-Catalyst Final Awards!
Funding for the 2025-2026 Catalyst Final Awards is made possible by generous co-funding contributions from the Weill Institute for Neurosciences and the School of Pharmacy, to complement the Innovation Ventures Catalyst and InVent Funds. We extend our gratitude for this program-level commitment to frontline innovation at UCSF.
Innovation Ventures extends sincere thanks to the multisector Catalyst Advisors and the dedicated Catalyst Interns. We have the full team listed below.
UCSF’s Innovation Ventures extends BIG THANKS!
To the Co-Funding teams providing expanded support of 2025-2026 Catalyst projects:
Weill Institute of Neurosciences:
Stephen L. Hauser, MD
Jon-Eric Vanleeuwen, PhD.
Lauren De Remer
UCSF School of Pharmacy:
Kathy Giacomini, PhD
Michelle Arkin, PhD
To the Catalyst Advisors
Therapeutics: Roxanne Croze, PhD; John Teare, PhD; Ken Haas, JD; Sriram Venkataraman, PhD; Erica Pascal, JD, PhD; Ram Mandalam, PhD; Toni Kline, PhD.
Medical Devices: Tony Fields, MS, MSc; Chris Jones, MS; David Pudwill, MS; Bret Foreman, MS; William Mavity, BS; Shahnaz Miri, MD, MBA; Chris Baker, MD; Michi Garrison, MS.
Digital and Computational Health: Rick Beberman, MBA; Shahnaz Miri, MD, MBA; Alperen Ozalp, MBA; Karim ReFaey, MD; Chris Jones, MS; Jon Freudman, MD; David Pudwill, MS; Heather Rubuelta, MBA; Kevin Hacker, PhD; Christopher Seaman, MA; Agatha Martingdale, CPA; Ravi Srinivasan, PhD; Shefali Talwar, PhD.
Diagnostics: Ken Fang, MD; Linda McAllister, MD, PhD; Maureen Cronin, PhD; John Teare, PhD.